Datopotamab deruxtecan
Datopotamab deruxtecan Uses, Dosage, Side Effects, Food Interaction and all others data.
Datopotamab deruxtecan is under investigation in clinical trial NCT04656652 (Study of DS-1062A Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer Without Actionable Genomic Alterations (TROPION-LUNG01)).
| Trade Name | Datopotamab deruxtecan |
| Generic | Datopotamab deruxtecan |
| Datopotamab deruxtecan Other Names | Datopotamab deruxtecan |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Datopotamab deruxtecan
